DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Guy H, Laskier V, Fisher M. , et al.
Cost-effectiveness of betrixaban compared with enoxaparin for venous thromboembolism prophylaxis in nonsurgical patients with acute medical illness in the United States.
Pharmacoeconomics 2019;
37 (05) 701-714
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.